About the Authors
- Henrik Aggerbeck
-
* E-mail: hea@ssi.dk (HA); sho@ssi.dk (STH)
Affiliation Department of Vaccine Development, Statens Serum Institut, Copenhagen, Denmark
- Rafaela Giemza
-
Affiliation Centre for Infection, St George’s University of London, London, United Kingdom
- Paulatsya Joshi
-
Affiliation Clinical Research Centre, Faculty of Health and Medical Sciences, University of Surrey Guildford, Guildford, United Kingdom
- Pernille N. Tingskov
-
Affiliation Department of Vaccine Development, Statens Serum Institut, Copenhagen, Denmark
- Søren T. Hoff
-
* E-mail: hea@ssi.dk (HA); sho@ssi.dk (STH)
Affiliation Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark
- Julia Boyle
-
Affiliation Clinical Research Centre, Faculty of Health and Medical Sciences, University of Surrey Guildford, Guildford, United Kingdom
- Peter Andersen
-
Affiliation Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark
- David J. M. Lewis
-
Affiliations Clinical Research Centre, Faculty of Health and Medical Sciences, University of Surrey Guildford, Guildford, United Kingdom, Centre for Infection, St George’s University of London, London, United Kingdom
Competing Interests
PA is co-inventor of a patent related to ESAT-6 but all rights belong to Statens Serum Institut. Patent name: Tuberculosis vaccine. No: WO9501441. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: DL HA STH PA. Performed the experiments: RG PJ JB DL. Analyzed the data: DL HA PT STH. Contributed reagents/materials/analysis tools: PT HA. Wrote the paper: HA DL PA STH.